Skip to content

Homoeopathic medicines for eructation

A double-blind, randomized, placebo - controlled, pilot trial of individualized homoeopathic medicines in Belching disorder in adults - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069356
Enrollment
60
Registered
2024-06-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R142- Eructation

Interventions

Intervention1: Individualized homoeopathic medicine in centesimal potencies along with dietary management: Intervention is planned as administering indicated homoeopathic medicines in centesimal poten
doses and repetition depend upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking, or brushing their teeth with
doses and repetition will be maintained depending upon the individual requirement of the cases. All items will be procured from a Good Manufacturing Practice (GMP) certified firm. Both medicines and p

Sponsors

The Calcutta Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who will fulfill ROME IV diagnostic criteria for belching disorders: a. Diagnostic Criteria for Belching Disorders Must include all the following: Bothersome (severe enough to impact on usual activities) belching from the esophagus or stomach more than 3 days a week. b. Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis. 2. Age between 18 and 65 years 3. Patients of either sex including transgender 4. Literate patients, ability to read English, Bengali or Hindi and illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires. 5. Willing to take part in the study and give written informed assent and/or consent voluntarily

Exclusion criteria

Exclusion criteria: 1. Patient of known case of any disease ofstomach or having any pathological condition causing belching (e.g.: GERD, Peptic ulcer, Gastritis, Gastroparesis, Dumping syndrome etc.) 2. Patients having any other systemic disease or having any life-threatening illness affecting quality of life or any other organ. 3. Necessary relevant diagnostic tests will be advised to exclude Patients having any pathological conditions or organic diseases. 4. Patients who are taking any medicines regularly for these complaints within last 6 weeks. 5. Vulnerable population- Unconscious, ambulatory, too ill for consultation, differently abled, terminally ill or critically ill patients, institutionalized persons, mentally disabled people. 6. Pregnant and postpartum women, nursing mothers. 7. Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other forms of substance abuse and/or dependence. 8. Self-reported immune-compromised condition. 9. Already been in homoeopathic treatment for any chronic illness for the last 6 months. 10. Simultaneous participation in any other clinical trial.

Design outcomes

Secondary

MeasureTime frame
NilTimepoint: NA

Primary

MeasureTime frame
Functional Digestive Disorder Quality of Life (FDDQL) QuestionnaireTimepoint: At baseline, every month, up to 3 months

Countries

India

Contacts

Public ContactHimangsu Hait

The Calcutta Homoeopathic Medical College and Hospital

haitdrhimangsu@gmail.com9433565680

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026